Friday, April 07, 2017 7:22:37 AM
additional $2,100,000 in Class A Units, with each Class A Unit consisting of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and a warrant to purchase half of one share of Common Stock, (ii) an additional $1,350,000 in Class B Units, with each Class B Unit consisting of one share of the Company’s Series A convertible preferred stock, par value $0.001 per share (the “Series A Preferred Stock”) and a warrant to purchase a number of shares of Common Stock equal to $1,000 divided by the conversion price of the Series A Preferred Stock, (iii) shares of Common Stock issuable upon conversion of the additional shares of Series A Preferred Stock and (iv) shares of Common Stock issuable upon exercise of the warrants issued under the additional Class A Units and Class B Units. The contents of the Registration Statement on Form S-1 (Registration No. 333-216663), as amended, including the exhibits and power of attorney thereto, which was declared effective by the Securities and Exchange Commission on April 6, 2017, are incorporated by reference in this Registration Statement.
Nothing I state is intended to be a recommendation to buy or sell, opinion only. Readers are solely responsible for how they use the information.
Recent CBIO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/02/2024 10:19:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2024 08:51:43 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2024 12:49:16 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2024 12:48:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2024 12:46:38 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/19/2024 08:06:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/09/2024 08:31:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/08/2024 10:03:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/05/2024 09:40:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/04/2024 09:27:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/03/2024 08:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2024 08:01:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2024 09:35:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2024 10:42:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2024 09:03:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2024 01:55:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/22/2024 12:31:12 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/22/2024 12:27:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2024 11:15:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2024 08:47:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/15/2024 09:29:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 10:16:03 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/24/2024 10:11:14 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/19/2024 09:05:30 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/12/2024 09:01:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM